|
1BFV
MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
Deposited 1997-05-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–113(113 aa)
Fragment:MONOCLONAL ANTIBODY FV FRAGMENT
|
Not recorded
|
ZN ZINC ION × 3
STG ESTRIOL 3-(B-D-GLUCURONIDE) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 18% (W/V) PEG 8000, 200MM ZN ACETATE AND 100MM NA CACODYLATE, PH 7.5
|
Resolution 2.10 Å
R-free 0.271
|
|
1BFV
MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
Deposited 1997-05-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
1–113(113 aa)
Fragment:MONOCLONAL ANTIBODY FV FRAGMENT
|
Not recorded
|
ZN ZINC ION × 6
STG ESTRIOL 3-(B-D-GLUCURONIDE) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 18% (W/V) PEG 8000, 200MM ZN ACETATE AND 100MM NA CACODYLATE, PH 7.5
|
Resolution 2.10 Å
R-free 0.271
|
|
1BFV
MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
Deposited 1997-05-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
1–113(113 aa)
Fragment:MONOCLONAL ANTIBODY FV FRAGMENT
|
Not recorded
|
ZN ZINC ION × 6
STG ESTRIOL 3-(B-D-GLUCURONIDE) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 18% (W/V) PEG 8000, 200MM ZN ACETATE AND 100MM NA CACODYLATE, PH 7.5
|
Resolution 2.10 Å
R-free 0.271
|
|
1BFV
MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
Deposited 1997-05-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–113(113 aa)
Fragment:MONOCLONAL ANTIBODY FV FRAGMENT
|
Not recorded
|
ZN ZINC ION × 3
STG ESTRIOL 3-(B-D-GLUCURONIDE) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 18% (W/V) PEG 8000, 200MM ZN ACETATE AND 100MM NA CACODYLATE, PH 7.5
|
Resolution 2.10 Å
R-free 0.271
|
|
1CFV
MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
Deposited 1997-04-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–113(113 aa)
Fragment:FV FRAGMENT
|
Not recorded
|
ZN ZINC ION × 3
E3G ESTRONE BETA-D-GLUCURONIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;PROTEIN WAS CRYSTALLIZED FROM 18% (W/V) PEG 8000, 200MM ZN ACETATE AND 100MM NA CACODYLATE, PH 7.0
|
Resolution 2.10 Å
R-free 0.247
|
|
1MAJ
SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
Deposited 1993-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–113(113 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1MAK
SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
Deposited 1993-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–113(113 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
2BFV
MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
Deposited 1997-05-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–113(113 aa)
Fragment:MONOCLONAL ANTIBODY FV FRAGMENT
|
Not recorded
|
STG ESTRIOL 3-(B-D-GLUCURONIDE) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;PROTEIN WAS CRYSTALLIZED FROM 15% (W/V) PEG 4000, 100MM NA ACETATE AND 50MM TRIS HCL PH 8.5
|
Resolution 2.50 Å
|
|
2DLF
HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75
Deposited 1998-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–113(113 aa)
Fragment:FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.75;CRYSTALLIZATION CONDITIONS: TEMPERATURE AT 20C. PRECIPITANT SOLUTION CONTAINED
1 AMMONIUM SULFATE AND 0.025 M SODIUM CACODYLATE (PH 6.75). 5 MG/ML OF FV
FRAGMENT., VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.55 Å
R-free 0.233
|